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Abstract
Recent studies have shown the contribution of miRNAs to cancer pathogenesis. Prostate cancer is the most commonly
diagnosed cancer in men. Unlike other major types of cancer, no single gene has been identified as being mutated in the
majority of prostate tumors. This implies that the expression profiling of genes, including the non-coding miRNAs, may
substantially vary across individual cases of this cancer. The within-class variability makes it possible to reconstruct or infer
disease-specific miRNA-mRNA correlation and regulatory modular networks using high-dimensional microarray data of
prostate tumor samples. Furthermore, since miRNAs and tumor suppressor genes are usually tissue specific, miRNA-mRNA
modules could potentially differ between primary prostate cancer (PPC) and metastatic prostate cancer (MPC). We herein
performed an in silico analysis to explore the miRNA-mRNA correlation network modules in the two tumor subtypes. Our
analysis identified 5 miRNA-mRNA module pairs (MPs) for PPC and MPC, respectively. Each MP includes one positive-
connection (correlation) module and one negative-connection (correlation) module. The number of miRNAs or mRNAs
(genes) in each module varies from 2 to 8 or from 6 to 622. The modules discovered for PPC are more informative than
those for MPC in terms of the implicated biological insights. In particular, one negative-connection module in PPC fits well
with the popularly recognized miRNA-mediated post-transcriptional regulation theory. That is, the 39UTR sequences of the
involved mRNAs (,620) are enriched with the target site motifs of the 7 modular miRNAs, has-miR-106b, -191, -19b, -92a, -
92b, -93, and -141. About 330 GO terms and KEGG pathways, including TGF-beta signaling pathway that maintains tissue
homeostasis and plays a crucial role in the suppression of the proliferation of cancer cells, are over-represented (adj.p,0.05)
in the modular gene list. These computationally identified modules provide remarkable biological evidence for the
interference of miRNAs in the development of prostate cancers and warrant additional follow-up in independent laboratory
studies.
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Introduction
MicroRNAs (miRNAs) are short (,22nt), non-coding RNAs
derived from genome-encoded stem loop precursors. As the crucial
post-transcriptional regulators of gene expression in metazoans,
miRNAs primarily bind to the 39 UTR sequences of messenger
RNAs (mRNAs), usually resulting in translational repression or
mRNA degradation [1,2]. It is estimated that ,30% of human
protein-coding genes are regulated by miRNAs, where each
miRNA can target approximately 200 transcripts and more than
one miRNA can converge onto a single mRNA target [2,3].
Numerous studies have shown that aberrantly expressed miRNAs
are likely to contribute to human diseases, including cancer
[4,5,6,7,8,9]. However, these small RNAs could not be the
‘‘cancer-drivers’’ [10] in the majority of cancer cases because the
evidences for their mutations in sematic cells are still relatively rare
[11,12]. This indicates that miRNAs themselves may be regulated
by other molecules such as transcription factors [13] and, in turn,
cooperatively play roles in disease progression by amplifying or
reducing the impact of the aberrations occurring in proto-
oncogenes and tumor suppressor genes. It has been recognized
that the interference of miRNAs with tumorigenesis is quite
complicated and needs to be scrutinized by the network-based
systems biology approaches.
To date, a number of algorithms have been developed to infer
miRNA-mRNA modules or modular networks using the genome-
wide transcription and sequence affinity information
[14,15,16,17]. Despite the diverse algorithmic designs and
computational complexities, the flow schemes of these methods
are fairly explicit and the definitions of a miRNA-mRNA module
carry similar characteristics. A fundamental module generally
consists of a set of co-expressed protein-coding genes and a
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expression level, or is a top predictor (among other regulators) for
the mRNA-set-determined classification trees of the biological
samples/‘‘conditions’’ [18,19,20]. Such a one-to-many type of
module can then be refined into a canonical miRNA-mRNA
regulatory module where the expressions of miRNAs and mRNAs
are in inverse relationship, and the complementary motifs of the
miRNAs’ seed sequences exist in the 39UTRs of the target genes
(mRNAs). Two or multiple one-to-many modules can further be
combined into a many-to-many module by identifying their
intersections [16].
Prostate cancer is the most commonly diagnosed cancer and the
second leading cause of cancer mortality in American men. Every
year, more than 200,000 new cases are diagnosed and over 30,000
adult males die from this disease [21]. Fatal outcome often occurs
when the local tumor infiltration has spread beyond the prostate
gland and metastasized to lymph nodes and other organs. Unlike
other major types of cancers, the genetic etiology of prostate
cancer is rather complex and heterogeneous. No single gene
mutation has been pinpointed in the majority of prostate tumors
[12,22,23]. This implies that the expression profiling of genes,
including non-coding miRNAs, may substantially vary across
individual cases in different stages or subtypes of prostate cancer.
The within-class variability, i.e. variability primarily due to the
intrinsic differences in molecular genetic mechanism among
sampled individuals of the same class, makes it possible to
reconstruct or infer the disease specific correlation and regulatory
(modular) networks using the high-dimensional microarray data of
prostate tumor samples. In particular, because miRNAs and
tumor suppressor genes are usually tissue specific [23,24], miRNA-
mRNA modules potentially differ between primary prostate
cancer (PPC) and metastatic prostate cancer (MPC). Our study
thus initiated from this perception and centered on the in silico
identification and comparison of miRNA-mRNA modules in PPC
and MPC. A recently released comprehensive database [12]
provided us the required information for such a bioinformatics
investigation. The obtained results provide remarkable biological
insight into the interference of miRNAs in the development of
prostate cancers. Figure 1 summarizes the scheme of our study
flow, and the details of each step are described in the Results and
Method sections.
Results and Discussion
SVD Analysis of miRNA-mRNA Interaction Matrices
Before inferring the miRNA-mRNA network modules for PPC
and MPC, we tried to obtain a general understanding of the
differences between those two correlation matrices calculated from
Figure 1. The schematic presentation of the study flow.
doi:10.1371/journal.pone.0040130.g001
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metastatic tumor samples, respectively (see the Method section
for details). However, due to the enormous number of potential
miRNA-mRNA regulatory or co-expressed relationships and the
complicated interplay among them, together with the noises
introduced into the sampling and measurement process, the
pairwise comparison of the corresponding matrix elements was too
trivial to reach a conclusion. We circumvented this obstacle by
employing a novel method. More specifically, we treated each
correlation matrix as a pseudo dataset with the rows (mRNAs) as
Figure 2. The singular value decomposition (SVD) analysis of miRNA-mRNA transcriptional correlation matrices. Before the
decomposition, Pearson correlation coefficients were transformed with Fisher’s r-z method. A1/B1/C1: the results obtained from the primary
prostate cancer (PPC) samples. A2/B2/C2: the results obtained from the metastatic prostate cancer (MPC) samples. A3/B3/C3: the results obtained
from a random data structure generated by shuffling the PPC matrix.
doi:10.1371/journal.pone.0040130.g002
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characterized it by conducting SVD (Singular Value Decompo-
sition) analysis [25,26,27,28]. Considering the values of correlation
coefficients were in the range of [-1, 1], we transformed the matrix
entries using Fisher’s r-z method prior to the decomposition so that
the results can be explained by the standard statistical theory.
This analysis led to two interesting findings. First, for both PPC
and MPC correlation matrices, the leading latent factor can
explain over half of the variance in data (Figure 2-A1, -A2), and
the scores (in the first left singular vector) across genes (Figure 2-
B1, -B2) show a clear two-peak distribution. Second, the PPC
matrix differs from the MPC matrix by a substantial second latent
factor that explains ,20% of the variance and has an asymmetric
score (in the second left singular vector) distribution (Figure 2-
C1), which deviates from the symmetric counterpart for MPC
(Figure 2-C2). The strength of this analysis is further highlighted
by the fact that the observed patterns are not present in a random
data set as shown in Figure 2-A3, -B3 and C3, where SVD
analysis was conducted on a matrix generated by shuffling the
rows and columns of the PPC matrix. While the biological
implications need to be further investigated, these findings
preliminarily confirmed our initial hypothesis that the dynamic
interference of miRNAs in those two types of prostate cancer can
be different and worth further exploration.
It is worth noting that, in preparing Figure 2, we used the
information of 58 cancer miRNAs collected in [7]. However, the
presented results largely held when the SVD analysis was
conducted on the entire datasets (matrices). In addition, we
recognize that the differences between the PPC and MPC can be
determined by a core set of miRNAs. This perception is based on
an additional analysis which showed that the patterns demon-
strated in Figure 2 also held on the sub-matrices with only the
tumor suppressor miRNAs, but not on the sub-matrices containing
the oncogene miRNAs exclusively. We will continue to investigate
this problem in future research.
miRNA-mRNA Modules in different Prostate Cancer
Subtypes
Two miRNA-mRNA networks (PN and MN) were generated by
a correlation-based method for PPC and MPC, respectively. In
order to focus the analysis on the cancer-related miRNAs, the
dimensions of PN and MN were further reduced as presented in
the Method section. With the condensed networks as inputs, major
cancer-related miRNA-mRNA modules were identified by a
clustering analysis-based algorithm. Within an individual module,
each miRNA or mRNA has at least two connections with the
corresponding modular mRNAs or miRNAs.
As summarized in Table 1, Figure 3 and Figure 4,w e
identified 5 miRNA-mRNA module pairs (MPs) for PPC and
MPC, respectively. Each MP includes one positive-connection
(correlation) module and one negative-connection (correlation)
module. The number of miRNAs or mRNAs (genes) in each
module varies from 2 to 8 or from 6 to 622. Most of the modules
contain the sequence-specific DNA binding transcription factor
(TF) genes [29] that may take roles as the mediators for the
miRNA-mRNA connections. The two members (such as p-modu-
Table 1. The summary of miRNA-mRNA correlation-network modules.
Module
a Gene number Number of TF genes
b miRNA
c
p-modu-1-ps 542 39 -1, -143, -145, -221, -222
p-modu-1-ne 113 7 -1, -143, -145, -221, -222
p-modu-2-ps 466 50 -181c, -224, -24, -27a
p-modu-2-ne 92 8 -181c, -224, -24, -27a
p-modu-3-ps 233 6 -7a, -7d, -7f, -7g, -7i, -126, -195, -98
p-modu-3-ne 6 0 -7a, -7d, -7f, -7g, -7i, -126, -195, -98
p-modu-4-ps 350 26 -146a, -150, -223
p-modu-4-ne 38 5 -146a, -150, -223
p-modu-5-ps 145 11 -106b, -141, -19a, -19b, -200c, -92a, -93
p-modu-5-ne 622 47 -106b, -141, -19a, -19b, -200c, -92a, -93
m-modu-1-ps 81 2 -17, -20a, -20b
m-modu-1-ne 15 0 -17, -20a, -20b
m-modu-2-ps 173 7 -200a, -200b
m-modu-2-ne 382 6 -200a, -200b
m-modu-3-ps 115 5 -15a, -26a, -29c
m-modu-3-ne 123 0 -15a, -26a, -29c
m-modu-4-ps 92 4 -7a, -7d, -7e, -7f, -98
m-modu-4-ne 138 2 -7a, -7d, -7e, -7f, -98
m-modu-5-ps 86 3 -107, -26b
m-modu-5-ne 182 3 -107, -26b
aThe modules in primary prostate cancer (PPC) or metastatic prostate cancer (MPC) are marked with the prefix ‘‘p-’’ or ‘‘m-’’. The positive or negative-connection
modules are marked with the extension ‘‘-ps’’ or ‘‘-ne’’.
b Only the sequence-specific DNA binding transcription factors were counted. The TF genes have been annotated
to one of the five GO terms: GO: 0003700 (sequence-specific DNA binding transcription factor activity), GO: 0003702 (RNA polymerase II transcription factor activity), GO:
0003709 (RNA polymerase III transcription factor activity), GO: 0016563 (transcription activator activity), and GO: 0016564 (transcription repressor activity).
c The prefix
‘‘hsa-miR’’ are omitted in the IDs. For a miRNA, the statistical significance of the target site enrichment level in the list of the correlated modular genes was measured by
the Fisher’s exact test in reference to the level of the entire gene set. The red bold font indicates p-value ,0.01.
doi:10.1371/journal.pone.0040130.t001
miRNA-mRNA Network Modules in Prostate Cancer
PLoS ONE | www.plosone.org 4 June 2012 | Volume 7 | Issue 6 | e401301-ps and p-modu-1-ne in PPC) of each MP contain the same
miRNAs but different mRNAs. Two modules of distinct MPs
(such as p-modu-1-ps and p-modu-2-ps in PPC) consist of different
miRNAs and varied (or partially overlapped) mRNA sets. Within
a positive or negative-connection module (with ‘‘-ps’’ or ‘‘-ne’’
extension in the IDs), the correlations of the involved miRNAs
and mRNAs at the expression levels are consistently positive or
negative. Regardless of the connection type, the mRNA set in
each module largely imitates a co-expressed gene cluster. Besides
the four modules of the two MPs (p-modu-3-ps (-ne) and m-modu-4-
ps (-ne)) in which most miRNAs belong to the let-7 family, the
modules for MPC hardly overlap with the modules for PPC in
terms of the involved miRNAs (Table 1) and protein-coding
genes (Table S1). Advanced insights regarding the differences
between PPC and MPC can be further inferred by a scrutiny of
the biological implications of the identified modules.
Here we need to point out that the identified modules are not
necessarily the canonical regulatory modules in which all the
connections between miRNAs and genes are determined by the
causal regulator-target relationships [30]. In fact, due to the
unsolved problem in accurately recognizing the miRNA target
sites [2], it is challenging to identify a nontrivial and exact
canonical regulatory module. Nonetheless, we can expect to find a
less strict regulatory module, called a ‘‘semi-canonical’’ regulatory
module hereafter, where the relationship potentially determined
by the miRNA-mediated mRNA degrading mechanism is
predominant among the miRNA-mRNA connections. Based on
this widely-accepted theory, semi-canonical regulatory modules, if
exist, should be among the negative-connection modules, and then
can be determined by the target site enrichment analysis. We did
this exploration by establishing the miRNA-mRNA sequence
affinity matrix and conducting Fisher’s exact test (see the Method
section). As a result, we found that p-modu-5-ne, a module identified
Figure 3. Identifying miRNA-mRNA correlation-network modules in primary prostate cancer (PPC) by the hierarchical clustering
algorithm. Red: the top 1% positive correlations. Yellow: the top 1% negative correlations. Orange: pseudo or unconsidered correlations.
doi:10.1371/journal.pone.0040130.g003
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sequences of the involved 622 mRNAs were significantly enriched
(p,1.0E24) with the target site motifs of the 7 modular miRNAs
(hsa-miR-106b, -200c, -19b, -92a, -92b, -93, and -141) (Figure 5).
This module, therefore, represents the most significant difference
between PPC and MPC in terms of the observed miRNA-mRNA
correlations. It suggests that the post-transcriptional regulation
mediated by the documented cancer miRNAs directly contribute
to the expression variability of the protein-coding genes across the
tumor samples for PPC but not for MPC.
The implications of the identified modules need to be further
inferred through the functional annotations of the modular genes,
since there is a great biomedical interest in elucidating the
relationships between the activity of modular miRNAs, as
regulators or biomarkers, and the variability of the specific
biological processes. Using the David database [31], we found that
over 330 GO terms and KEGG pathways, including the TGF-
beta signaling pathway, were over-represented (BH adj.p,0.05)
with the 622 genes of the semi-canonical module p-modu-5-ne. The
genes within other individual modules also demonstrated the
significant functional similarity. For example, m-modu-4-ne, a
negative-connection module discovered for MPC, was enriched
with the genes in the GO:0007186,G-protein coupled protein
signaling pathway (BH adj.p =1.14E240). Table S2 summa-
rized the functional enrichment analysis results of the modular
genes.
We also examined the differences between these two prostate
cancer subtypes by studying the distributional profile of the
KEGG pathways over-represented in the individual modular gene
set. As shown in Figure 6, module p-modu-4-ps for PPC is unique
among the identified modules regarding the functions of the
modular genes. About two dozen of the pathways, such as type I
Figure 4. Identifying miRNA-mRNA correlation-network modules in metastatic prostate cancer (MPC) by the hierarchical clustering
algorithm. Red: the top 1% positive correlations. Yellow: the top 1% negative correlations. Orange: pseudo or unconsidered correlations.
doi:10.1371/journal.pone.0040130.g004
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them are related to disease process and/or immune response.
Three miRNAs (hsa-miR-146a, -150 and -223) are included in this
module. The involvement of miR-146a in the immune response
has been widely investigated. [32] showed that miR-146a is a
modulator of IL-2 and activation-induced cell death in lympho-
cytes. [33] reported that it mediates an inflammatory circuit in
Alzheimer disease and stressed human brain cells. Another study
[34] also demonstrated that HSV-1 infection in human brain cell
can induce the expression of miR-146a. Apparently, these findings
not only indicate that miR-146a takes a functional role in immune
response as a regulatory factor, but also suggest that its dynamic
activity (expression), in some specific contexts, may just serve as
the passenger of disease and/or immune processes [10]. This is
exactly the main message conveyed by the module p-modu-4-ps
where the positive correlations between the modular miRNAs and
genes could not be simply explained by a regulator-target
mechanism.
Olfactory receptors (ORs) are expressed not only in the sensory
neurons of the olfactory epithelium, but also in various other
tissues where their potential functions are largely unknown. In a
recent publication, the authors reported that the activation of an
olfactory receptor (PSGR) inhibits proliferation of prostate cancer
cells [35]. The results from our analysis show that olfactory
transduction (pathway) is over-represented in the gene list of 4
major modules (m-modu-2-ne, m-modu-3-ne, m-modu-4-ne, m-modu-5-
ne) in MPC (Figure 6). The involved miRNAs include hsa-miR-
200a/-200b, hsa-miR-15a/26a/29c, hsa-miR-7a/-7e/-7f/-98,
and hsa-miR-107/-26b. Although the miRNA set in p-modu-3-ps
(-ne) largely overlapped with that in m-modu-4-ne, no module in
PPC has a functional relationship with olfactory conduction.
Therefore, we speculate that the activation of PSGR and the
(direct or indirect) association with miRNAs are only confined to
MPC.
Focal-adhesion kinase (FAK) is an important mediator for
growth-factor signaling, cell proliferation, cell survival and cell
migration. Mouse models have shown that FAK expression is
increased in human tumors [36]. A recent study demonstrated
that focal adhesion controls prostate cancer progression [37]. In
this study, we found that miRNAs interfere in the transduction of
FAK signaling, thus may take roles in cancer development. As
shown in Figure 6, focal adhesion (together with 6 related
KEGG pathways such as ECM-receptor interaction) is over-
represented in the gene lists of 3 major modules identified for
PPC (p-modu-1-ps, p-modu-2-ps, p-modu-5-ne). Opposite to the cases
of olfactory transduction for MPC, the association of by a
hierarchical clustering algorithm FAK signaling with miRNAs
seems limited to PPC. These findings indicate another major
difference between the two cancer subtypes. Experimental
investigation on this issue could be promising for the diagnosis
of prostate cancer.
Potential Interference of miRNAs in TGF-beta Signaling
Pathway
The transforming growth factor-beta (TGF-beta) maintains
tissue homeostasis and plays a crucial role in the suppression of
the proliferation of cancer cells [23,38]. As mentioned above,
the TGF-beta signaling pathway is over-represented in the gene
(mRNAs) set of the semi-canonical regulatory module, p-modu-5-
ne. Of the 622 modular genes, a dozen of them encode proteins
in the pathway. These 12 genes demonstrate 56 negative-
connections with the 7 modular miRNAs, and nearly one third
of the connections are compatible with the potential regulator-
target relationships determined by the sequence affinity infor-
mation (Figure 7). Based on this finding and the theories
described in [23] (pages 198–224), we generated a hypothesized
model (Figure 8) to show the interference of the modular
miRNAs with the TGF-beta signaling and the proliferation of
cancer cells. In Figure 8, the genes negatively correlated with
the miRNAs in the modular network are highlighted in red.
Gene CDKN1A is also marked in red because of its significant
negative correlations (p,0.001) with hsa-miR-93, -106b and
Figure 5. miRNA target site enrichment analysis for module p-modu-5-ne.
doi:10.1371/journal.pone.0040130.g005
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CDK4 show an apparent pattern of positive transcriptional
correlations with the modular miRNAs and are highlighted in
yellow. The relationships presented in Figure 8 suggest that the
modular miRNAs interfere with the disease process of the
primary prostate cancer by an oncogenic mechanism in the
measured PPC samples. More specifically, the expression of
those miRNAs inversely regulates the transcript intensity of two
GF-beta genes, TGFBR1 and TGFBR2, and a cancer
suppression gene SMAD3. Then, through the activation or
inactivation of the Smad2-3/Smad4/E2f complex, this effect is
reflected on the expression levels of CDKN1A and CMYC, and
finally influences the cell cycle arrest and cell proliferation
inhibition.
Expression Variability of miRNAs in Module p-modu-5-ne
As discussed above, in p-modu-5-ne, the identified miRNAs
directly regulate the transcript intensities of the modular mRNAs
in the PPC samples. In this regard, it is important to elucidate the
etiology of the biological variability (across tumor samples) of the
miRNA expression levels that determine the miRNA-mRNA
connections. First, we noted that most of the identified miRNAs,
including hsa-miR-19b, -92a, -93 and -106b, have been reported as
the targets of the transcription factors of the E2F family [13,39].
Meanwhile,wealsoobservedthepositiveconnectionsbetweenthese
miRNAs and E2F5 at the expression levels (Figures 8 and 9).
Therefore,therewasapossibilitythatthebiologicalvariabilityofthe
miRNAs was due to the regulation by E2F5. However, such a
mechanism needs to be further investigated since the actual picture
of the regulation and/or mutation of the TF gene itself is still not
clear. Next, we asked if the modular miRNA expression levels were
related to the progression of prostate cancer. To investigate this
Figure 6. Over-represented KEGG pathways in the individual modular gene sets of 10 major miRNA-mRNA modules discovered
for primary prostate cancer (PPC) or metastatic prostate cancer (MPC). The ordinary p-values were adjusted with BH method.
doi:10.1371/journal.pone.0040130.g006
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7 modular miRNAs by a hierarchical clustering algorithm and
compared the result with the Gleason score-based classes. No
association was found between the two partitions. Finally, we
proposedandtestedahypothesisthatthebiologicalvariabilityofthe
miRNAs was sourced from the regulation by the protein-coding
genes (including cancer genes) on which mutations sporadically
occurred in individual tumor samples. By clustering analysis, we
firstly generated two partitions of the 98 PPC samples, respectively
based on the expression levels of all the 7 module miRNAs and the
transcript intensities of 34 potential cancer-driving genes in the
tumor samples as shown in the figure-1 of [12]. Then by a Chi-
square test, we found the association between the two partitions was
extremely significant (p,0.001), indicating our hypothesis can be
confirmed in this way.
Materials and Methods
Data Sets
The microarray data was published in the Gene Expression
Omnibus (GEO, a MIAME compliant database) repository with
accession number GSE21032 [12,40]. Among the 218 biological
samples included in the super-series, 98 primary tumors, 13
metastatic tumors and 28 normal prostate tissue samples (N
=139) have both miRNA and mRNA expression profiles.
Rigorous criteria have been applied in selecting tumors for the
genomic analysis [12]. The gene (mRNA) expression profiles
were measured with Affymetrix Human Exon 1.0 ST Array
[probe set (exon) version], and the images were quantified using
the GeneChip Operating Software (GCOS) version 1.4. The
Raw data were processed by Aroma Affymetrix. The standard
RMA background adjustment and quantile normalization were
performed. The miRNA expressions were measured on the
platform of Agilent-019118 Human miRNA Microarray 2.0
G4470B, and the images were quantified using Agilent Feature
Extraction version 9.5. The data were normalized with between-
array variance stabilization normalization (VSN) after excluding
the microRNAs not present in over 80% of the profiled samples.
In this study, the mRNA data (the downloaded Series Matrix
File) was further simplified by following procedure. First, we
adapted the gene expression values that originally centered on
Affymatrix_Exon_Gene_IDs (Affy_IDs) to the official gene
symbols by calculating the mean for a gene with two or multiple
Affy_IDs. Second, the adapted gene expression values were
transformed into log2 scale. Finally, we filtered out the genes that
lack of expression variability across the 139 arrays. With a cutoff
of a two-fold change from the maximum expression intensity to
the minimum one, , 5730 genes passed the filter. Therefore, the
final miRNA datasets contains 5730 genes and 377 miRNAs.
While the information of the 28 normal tissue samples was
considered in the data preprocessing to dilute the potential noise
in the microarray experiments, we focused on the PPC and MPC
samples in the following SVD analysis and miRNA-mRNA
module identification.
Computation of miRNA-mRNA Correlation Matrices
We used a computationally intensive method to estimate the
expression correlation between a miRNA and an mRNA. The
calculation of Pearson correlation was repeated 1000 times. In
each run, 80% of the randomly-selected PPC or MPC samples
Figure 7. Modular miRNA-mRNA network for TGF-beta signaling pathway. The sub-network was extracted for modules p-module-5-ne(ps).
All the connections except for those related to E2F5 are negative. Signal + indicates that at least one miRNA-target-site motif exists in the 39 UTR
sequence of the connected mRNA (gene).
doi:10.1371/journal.pone.0040130.g007
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results over the 1000 replications.
Generation of miRNA-mRNA Correlation Networks
We respectively generated two miRNA-mRNA correlation
networks, PN and MN, for PPC and MPC by discretizing the
expression correlation matrices with 5730 genes (mRNAs) as rows
and 377 miRNAs as columns. More specifically, we filled in both
matrices with 1 for the top 1% of the positive miRNA-mRNA
correlations, -1 for the top 1% of the negative correlations, and 0
for the rest of the entries. Thus, a non-zero element represents a
positive or negative correlation for a pair of miRNA and mRNA.
A correlation defined in such a way corresponds to a miRNA-
mRNA connection with the BH adjusted p-value ,0.008 (or
,0.065) for PPC (or MPC).
Identification of miRNA-mRNA Modules
Both discretized correlation matrices were condensed by
excluding the miRNAs lack of recorded relationships with cancers
and the genes of no connection with the cancer-related miRNAs.
That is, the columns corresponding to the miRNAs not included in
the documented list in [7] were firstly removed, and then the rows
(genes) which did not contain at least two non-zero entries were
excluded. The condensed PN and MN thus contain 58 columns,
and 1792 and 1340 rows, respectively. With the refined network
matrices as inputs, two heatmaps were generated respectively for
Figure 8. The interference of miRNAs in module p-module-5-ne in TGF-beta signaling pathway. The genes which have negative
connections with the miRNAs in the modular network are shaded with red. Gene CDKN1A (albeit not in the module gene list) is also shaded with red
because of the significant negative correlations (p,0.001) with hsa-miR-93, -106b and -200c at the expression level. Genes E2F5, MYC (CMYC) and
CDK4, demonstrating an apparent pattern of positive transcriptional correlations with the modular miRNAs (Figure 9), are shaded with yellow.
doi:10.1371/journal.pone.0040130.g008
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package ‘‘gplots’’. The layout of miRNAs and mRNAs in the
heatmaps were based on a two-way hierarchical clustering analysis
with Manhattan distance and Ward method as the arguments.
Taking PPC as an example (Figure 3), we identified the miRNA-
mRNA modules via the following three steps. (1) Based on the
dendrogram and the miRNA-mRNA connection patterns shown
on the heatmap, five modular miRNA subsets (clusters) were
visually determined. (2) For each of the miRNA subsets, the
positive or negative connections with mRNAs were collected into a
couple of 2-column topology matrices, respectively. (3) A miRNA-
mRNA module pair was identified from the outputs of step (2)
after dropping the mRNAs with only one (positive or negative)
connection. Figures of the modular networks were produced by
Cytoscape 2.8.1 [41].
Target Site Enrichment Test
Using a lab-owned R program with the core being the
matchPattern() function in the Bioconductor Biostrings [42,43], we
identified the 7-mer and 8-mer miRNA target site motifs on the 39
UTR sequences (retrieved from hg-18) of the genes measured in
the employed microarray data. The binary miRNA-mRNA
sequence affinity matrix (A) was then generated in a way such
that an element (Aij) of value 1 indicated the existence of target site
motif (s) for the j
th miRNA in the 39 UTR sequence of the i
th
mRNA. For a miRNA, the statistical significance of the target site
enrichment level in the list of the correlated modular genes was
measured by the Fisher’s exact test in reference to the level of the
entire gene set.
Figure 9. The transcriptional correlations of miRNAs in modules p-module-5-ne (ps) with TGF-beta signaling pathway downstream
genes. The number presented on each cell is the p-value of the correlation for the corresponding miRNA and mRNA (gene).
doi:10.1371/journal.pone.0040130.g009
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Table S1 The summary of miRNA-mRNA correlation-
network modules.
(TXT)
Table S2 The summary of functional enrichment anal-
ysis of gene lists in the identified miRNA-mRNA
correlation-network modules. The BH adjusted p-values
are listed. NA indicates that adj.p is .0.05 or no gene in the
module has been annotated to the GO terms (or the KEGG
pathway).
(TXT)
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